Abstract
Pirbenicillin, a semisynthetic penicillin, showed greater in vitro activity against 68 recent isolates of Pseudomonas aeruginosa than did ticarcillin or carbenicillin. The median minimum inhibitory concentration of each of these three compounds, respectively, was 3.1, 12.5, and 25 μg/ml when a 10−4 dilution of an overnight culture (about 105 colony-forming units [CFU]/ml) was used as inoculum, but these differences were less striking when larger inocula were used: at 107 CFU/ml these values were 6.25, 12.5, and 50 μg/ml, and at 108 to 109 CFU/ml these values were 50, 50, and 100 μg/ml. All three compounds showed greater inhibitory activity at pH 6 than at pH 8. This pH effect was greatest with pirbenicillin, for 6.25 μg of pirbenicillin per ml inhibited 7, 11, and 57% of the strains at pH 6, 7, and 8, respectively; these values were 4, 4, and 11% with ticarcillin and 0, 0, and 7% with carbenicillin. At sufficient inhibitory concentrations, the rates of bacterial killing of the three compounds were similar. The observed differences in anti-pseudomonad activity were not due to differences in stability to pseudomonad β-lactamases, but all three compounds were more stable than were cefazolin, cephaloridine, and benzylpenicillin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altemeier W. A., Todd J. C., Inge W. W. Gram-negative septicemia: a growing threat. Ann Surg. 1967 Oct;166(4):530–542. doi: 10.1097/00000658-196710000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brown C. H., 3rd, Natelson E. A., Bradshaw W., Williams T. W., Jr, Alfrey C. P., Jr The hemostatic defect produced by carbenicillin. N Engl J Med. 1974 Aug 8;291(6):265–270. doi: 10.1056/NEJM197408082910601. [DOI] [PubMed] [Google Scholar]
- DuPont H. L., Spink W. W. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 Jul;48(4):307–332. doi: 10.1097/00005792-196907000-00003. [DOI] [PubMed] [Google Scholar]
- EAGLE H., MUSSELMAN A. D. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J Exp Med. 1948 Jul;88(1):99–131. doi: 10.1084/jem.88.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kirby W. M. BACTERIOSTATIC AND LYTIC ACTIONS OF PENICILLIN ON SENSITIVE AND RESISTANT STAPHYLOCOCCI. J Clin Invest. 1945 Mar;24(2):165–169. doi: 10.1172/JCI101593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klastersky J., Vanderklen B., Daneau D., Mathiew M. Carbenicillin and hypokalemia. Ann Intern Med. 1973 May;78(5):774–775. doi: 10.7326/0003-4819-78-5-774. [DOI] [PubMed] [Google Scholar]
- Retsema J. A., English A. R., Lynch J. E. Laboratory studies with a new broad-spectrum penicillin, pirbenicillin. Antimicrob Agents Chemother. 1976 Jun;9(6):975–982. doi: 10.1128/aac.9.6.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sabath L. D., Jago M., Abraham E. P. Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea. Biochem J. 1965 Sep;96(3):739–752. doi: 10.1042/bj0960739. [DOI] [PMC free article] [PubMed] [Google Scholar]